BB-301, an investigational gene therapy, aims to address the underlying cause of the disease. The study's methodology involved blinded assessments to ensure objective evaluation of VFSS and SSQ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback